SMARCB1 and schwannoma: LOH analysis indicated that the mutant SMARCB1 allele was retained in two schwannomas and the leiomyosarcoma of the patient, whereas the wild-type allele was lost, indicative of biallelic SMARCB1 inactivation in both types of tumour (Paganini et al. 2015a).